Nexell Therapeuitcs Incorporated

Nexell Therapeutics Inc.(NASDAQ: NEXL), formerly known as VIMRX Pharmaceuticals Inc., is the leading developer and marketer of innovative diagnostics and ex vivo cell therapies for cancer, autoimmune, metabolic and genetic diseases. Nexell’s lead product, the Isolex® Cell Selection System, is marketed in a number of countries and is currently under final review by the FDA in the United States. In addition, Nexell markets an extensive line of cell therapy preparation, storage and expansion products including the Cryocyte™ and Lifecell® brands.

Contact Details: 9 Parker Irvine CA 92618-1605 United States of America Tel: 949 470 9011 Fax: 949 586 2420 Email: WWW: www.nexellinc.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 323 times since April 2007, the link to the organisation's website has been followed 81 times

Search for more companies in Irvine

Search for more companies in CA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Nexell Therapeuitcs Incorporated